Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Change in Account Payables (2020 - 2025)

Treace Medical Concepts' Change in Account Payables history spans 6 years, with the latest figure at -$9.4 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 15.38% year-over-year to -$9.4 million; the TTM value through Dec 2025 reached -$3.8 million, down 189.11%, while the annual FY2025 figure was -$3.8 million, 189.11% down from the prior year.
  • Change in Account Payables reached -$9.4 million in Q4 2025 per TMCI's latest filing, down from -$3.9 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $9.3 million in Q1 2024 to a low of -$9.4 million in Q4 2025.
  • Average Change in Account Payables over 5 years is $223050.0, with a median of $555000.0 recorded in 2023.
  • Peak YoY movement for Change in Account Payables: soared 1098.33% in 2022, then tumbled 769.44% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $1.6 million in 2021, then plummeted by 51.24% to $787000.0 in 2022, then soared by 300.89% to $3.2 million in 2023, then plummeted by 357.59% to -$8.1 million in 2024, then decreased by 15.38% to -$9.4 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Change in Account Payables are -$9.4 million (Q4 2025), -$3.9 million (Q3 2025), and $6.7 million (Q2 2025).